Abstract
The effects of a proprietary topical formulation containing EGCG-stearate in 100% glycerin USP were studied in two volunteer patients with recurrent herpes simplex (HSV) type 1. Application during early onset (prodromal stage) in a patient with herpes labialis prevented lesion progression. In a second patient with herpetic stomatitis, application of the formula during a later stage (inflammation stage) led to a remarkably shortened duration of symptoms. In contrast, a third patient provided 100% glycerin USP only as placebo failed to demonstrate any therapeutic or preventive effect against lesion occurrence or duration of lesion and healing time. These results suggest that this proprietary topical preparation could be used effectively to prevent and treat HSV-induced symptoms, and warrants further clinical investigation.
Keywords: Cold sore, green tea polyphenol, herpes labialis, herpes simplex virus, herpes stomatitis, EGCG-Stearate, proprietary topical preparation, EGCG-acyl ester, HSV-1, HSV-2.
Inflammation & Allergy - Drug Targets (Discontinued)
Title:A Proprietary Topical Preparation Containing EGCG-Stearate and Glycerin with Inhibitory Effects on Herpes Simplex Virus: Case Study
Volume: 11 Issue: 5
Author(s): Man Zhao, Jinyan Jiang, Rongrong Zheng, Henna Pearl, Douglas Dickinson, Baiping Fu and Stephen Hsu
Affiliation:
Keywords: Cold sore, green tea polyphenol, herpes labialis, herpes simplex virus, herpes stomatitis, EGCG-Stearate, proprietary topical preparation, EGCG-acyl ester, HSV-1, HSV-2.
Abstract: The effects of a proprietary topical formulation containing EGCG-stearate in 100% glycerin USP were studied in two volunteer patients with recurrent herpes simplex (HSV) type 1. Application during early onset (prodromal stage) in a patient with herpes labialis prevented lesion progression. In a second patient with herpetic stomatitis, application of the formula during a later stage (inflammation stage) led to a remarkably shortened duration of symptoms. In contrast, a third patient provided 100% glycerin USP only as placebo failed to demonstrate any therapeutic or preventive effect against lesion occurrence or duration of lesion and healing time. These results suggest that this proprietary topical preparation could be used effectively to prevent and treat HSV-induced symptoms, and warrants further clinical investigation.
Export Options
About this article
Cite this article as:
Zhao Man, Jiang Jinyan, Zheng Rongrong, Pearl Henna, Dickinson Douglas, Fu Baiping and Hsu Stephen, A Proprietary Topical Preparation Containing EGCG-Stearate and Glycerin with Inhibitory Effects on Herpes Simplex Virus: Case Study, Inflammation & Allergy - Drug Targets (Discontinued) 2012; 11 (5) . https://dx.doi.org/10.2174/187152812803251033
DOI https://dx.doi.org/10.2174/187152812803251033 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Tumour Re-Differentiation Effect of Retinoic Acid: A Novel Therapeutic Approach for Advanced Thyroid Cancer
Current Pharmaceutical Design The Pathogenesis, Complications and Therapeutic Strategy for Hepatitis C Virus-associated Insulin Resistance in the Era of Anti-viral Treatment
Reviews on Recent Clinical Trials The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells
Current Cancer Drug Targets Drug Metabolism and Pharmacokinetics of Dammarane Triterpenoids
Current Drug Metabolism Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases
Current Pharmaceutical Design Neurotransmitter Effects in Human Immunodeficiency Virus (HIV) and Simian Immuno-Deficiency Virus (SIV) Infection
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Disease Modifying Therapeutic Strategies in Alzheimers Disease Targeting the Amyloid Cascade
Current Neuropharmacology Pharmacogenetically Tailored Treatments for Heart Disease
Current Pharmaceutical Design Treatment of Large Vessel Vasculitis
Current Immunology Reviews (Discontinued) mGlu5, Dopamine D<sub>2</sub> and Adenosine A<sub>2A</sub> Receptors in L-DOPA-induced Dyskinesias
Current Neuropharmacology Pharmacology of TRP Channels in the Vasculature
Current Vascular Pharmacology Physiology, Affecting Factors and Strategies for Control of Pig Meat Intramuscular Fat
Recent Patents on Food, Nutrition & Agriculture Gene Therapy with Transcription Factor Decoy Oligonucleotides as a Potential Treatment for Cardiovascular Diseases
Current Drug Targets Regulators of the G1 Phase of the Cell Cycle and Neurogenesis
Central Nervous System Agents in Medicinal Chemistry Anti-Neuroinflammatory Properties of n-3 Fatty Acids and Nano- Curcumin on Migraine Patients from Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial
Endocrine, Metabolic & Immune Disorders - Drug Targets Design of β-turn Based Therapeutic Agents
Current Pharmaceutical Design Engineered E. coli as Vehicles for Targeted Therapeutics
Current Gene Therapy The Thyroid Gland: A Crossroad in Inflammation-Induced Carcinoma? An Ongoing Debate with New Therapeutic Potential.
Current Medicinal Chemistry Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease
Current Pharmaceutical Design Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance
Current Medicinal Chemistry